203 related articles for article (PubMed ID: 9155825)
1. Perception of airway obstruction in asthma: sequential daily analyses of symptoms, peak expiratory flow rate, and mood.
Apter AJ; Affleck G; Reisine ST; Tennen HA; Barrows E; Wells M; Willard A; ZuWallack RL
J Allergy Clin Immunol; 1997 May; 99(5):605-12. PubMed ID: 9155825
[TBL] [Abstract][Full Text] [Related]
2. Mood states associated with transitory changes in asthma symptoms and peak expiratory flow.
Affleck G; Apter A; Tennen H; Reisine S; Barrows E; Willard A; Unger J; ZuWallack R
Psychosom Med; 2000; 62(1):61-8. PubMed ID: 10705912
[TBL] [Abstract][Full Text] [Related]
3. Training perception of air flow obstruction in asthmatics.
Silverman BA; Mayer D; Sabinsky R; Williams-Akita A; Feldman J; Schneider AT; Chiaramonte LT
Ann Allergy; 1987 Nov; 59(5):350-4. PubMed ID: 3688560
[TBL] [Abstract][Full Text] [Related]
4. Relationship between symptoms and objective measures of airway obstruction in asthmatic patients.
Liam CK; Goh CT; Isahak M; Lim KH; Wong CM
Asian Pac J Allergy Immunol; 2001 Jun; 19(2):79-83. PubMed ID: 11699724
[TBL] [Abstract][Full Text] [Related]
5. Spirometric patterns in childhood asthma: peak flow compared with other indices.
Klein RB; Fritz GK; Yeung A; McQuaid EL; Mansell A
Pediatr Pulmonol; 1995 Dec; 20(6):372-9. PubMed ID: 8649917
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of asthma control using patient based measures and peak expiratory flow rate.
Pinto Pereira LM; Boodoo S; Dindial KA; Hosein A; Seemungal TA; Bekele I
West Indian Med J; 2009 Jun; 58(3):214-8. PubMed ID: 20043527
[TBL] [Abstract][Full Text] [Related]
7. Symptom perception and adherence to asthma controller medications.
Ohm R; Aaronson LS
J Nurs Scholarsh; 2006; 38(3):292-7. PubMed ID: 17044348
[TBL] [Abstract][Full Text] [Related]
8. Relationship between changes in diurnal variation of expiratory flows, lung volumes and respiratory symptoms after acute asthma.
Boulet LP; Milot J; Turcotte H
Respir Med; 1991 Nov; 85(6):487-93. PubMed ID: 1775675
[TBL] [Abstract][Full Text] [Related]
9. Peak expiratory flow rate underestimates severity of airflow obstruction in acute asthma.
Choi IS; Koh YI; Lim H
Korean J Intern Med; 2002 Sep; 17(3):174-9. PubMed ID: 12298428
[TBL] [Abstract][Full Text] [Related]
10. Persistence of airway obstruction and hyperresponsiveness in subjects with asthma remission.
Boulet LP; Turcotte H; Brochu A
Chest; 1994 Apr; 105(4):1024-31. PubMed ID: 8162720
[TBL] [Abstract][Full Text] [Related]
11. Relationship between spontaneous dyspnoea and lability of airway obstruction in asthma.
Peiffer C; Toumi M; Razzouk H; Marsac J; Lockhart A
Clin Sci (Lond); 1992 Jun; 82(6):717-24. PubMed ID: 1320553
[TBL] [Abstract][Full Text] [Related]
12. Effect of asthma severity on symptom perception in childhood asthma.
Cabral AL; Conceição GM; Saldiva PH; Martins MA
Braz J Med Biol Res; 2002 Mar; 35(3):319-27. PubMed ID: 11887209
[TBL] [Abstract][Full Text] [Related]
13. Chronobiological study of the relationship between dyspnoea and airway obstruction in symptomatic asthmatic subjects.
Peiffer C; Marsac J; Lockhart A
Clin Sci (Lond); 1989 Sep; 77(3):237-44. PubMed ID: 2805590
[TBL] [Abstract][Full Text] [Related]
14. Peak expiratory flow rate and symptom self-monitoring of asthma initiated from community pharmacies.
Bheekie A; Syce JA; Weinberg EG
J Clin Pharm Ther; 2001 Aug; 26(4):287-96. PubMed ID: 11493372
[TBL] [Abstract][Full Text] [Related]
15. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
[TBL] [Abstract][Full Text] [Related]
16. Reversal of bronchial obstruction with bi-level positive airway pressure and nebulization in patients with acute asthma.
Brandao DC; Lima VM; Filho VG; Silva TS; Campos TF; Dean E; de Andrade AD
J Asthma; 2009 May; 46(4):356-61. PubMed ID: 19484669
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of and tolerance to salmeterol compared to salbutamol in patients with bronchial asthma].
De Oliveira MA; Jardim JR; Faresin SM; Lucas SR; Nery LE
Rev Assoc Med Bras (1992); 1998; 44(3):169-75. PubMed ID: 9755543
[TBL] [Abstract][Full Text] [Related]
18. Symptom perception and functional morbidity across a 1-year follow-up in pediatric asthma.
Feldman JM; McQuaid EL; Klein RB; Kopel SJ; Nassau JH; Mitchell DK; Wamboldt MZ; Fritz GK
Pediatr Pulmonol; 2007 Apr; 42(4):339-47. PubMed ID: 17358038
[TBL] [Abstract][Full Text] [Related]
19. The effect of inhaled albuterol in moderate to severe asthma.
Apter AJ; Reisine ST; Willard A; Clive J; Wells M; Metersky M; McNally D; ZuWallack RL
J Allergy Clin Immunol; 1996 Aug; 98(2):295-301. PubMed ID: 8757206
[TBL] [Abstract][Full Text] [Related]
20. A randomized clinical trial of magnesium sulphate as a vehicle for nebulized salbutamol in the treatment of moderate to severe asthma attacks.
Kokturk N; Turktas H; Kara P; Mullaoglu S; Yilmaz F; Karamercan A
Pulm Pharmacol Ther; 2005; 18(6):416-21. PubMed ID: 15953743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
